Kelvin Kwan N. Lau, MD, Assistant Professor of Surgery at the Lewis Katz School of Medicine at Temple University, provided perspective to Reuters Health on a medical records analysis published in the Journal of the American College of Surgeons that showed the Albumin-Bilirubin (ALBI) score more accurately predicted outcomes in patients undergoing pulmonary, elective colorectal and adrenal operations than the Model for End Stage Liver Disease-sodium (MELD-Na). Dr. Lau is the study’s corresponding author. MD Alert and Medscape picked up the Reuters Health article.
Important announcement concerning Temple Health and Keystone First. Our provider agreement with Keystone First is scheduled to end on July 31st. Click the link below to learn about your options for continuing care at Temple Health.
Learn More
800-TEMPLE-MED
Schedule Appointment
SEARCH TEMPLE HEALTH